´ëÇѾÏÇÐȸ AACR-KCA Joint Conference on Precision Medicine in Solid Tumors 1 : 2018-11-15±³À°ÀÏÀÚ : 2018-11-15
±³À°Àå¼Ò : ¼¿ï·Ôµ¥È£ÅÚ Crystal Ballroom èâ
±³À°ÁÖÁ¦ :
AACR-KCA Joint Conference on Precision Medicine in Solid Tumors 1ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-792-1486
À̸ÞÀÏ :
cancer4@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢±â°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 9 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í 1.Á¶±âµî·Ï: 1)ȸ¿ø(AACR ¶Ç´Â KCA): 20¸¸¿ø, 2)ºñȸ¿ø: 30¸¸¿ø, 3)Çлý,Trainee: 10¸¸¿ø/ 2.»çÀüµî·Ï: 1)ȸ¿ø(AACR ¶Ç´Â KCA): 30¸¸¿ø, 2)ºñȸ¿ø: 40¸¸¿ø, 3)Çлý,Trainee: 15¸¸¿ø/ 3.ÇöÀåµî·Ï: 1)ȸ¿ø(AACR ¶Ç´Â KCA): 40¸¸¿ø, 2)ºñȸ¿ø: 50¸¸¿ø, 3) Çлý,Trainee: 20¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 08:30~08:55 Precision medicine in lung cancer: Prime time ¾È¸íÁÖ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 08:55~09:20 The Umbrella Trial in GC: Understanding the disease through genomics ÀÌÁö¿¬(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 09:20~09:45 Tumor agnostic drug development: Revisiting the score card in 2018 Alexander E. Drilon(Memorial Sloan Kettering Cancer Center, USA)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 09:45~10:10 Overview of genomic technologies Elaine R. Mardis(Nationwide Children)
ÈÞ½Ä 11¿ù 15ÀÏ 10:10~10:30 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 10:40~11:20 Precision medicine in lung cancer: Opportunities & challenges Waun Ki Hong(The University of Texas MD Anderson Cancer Center, USA)
½Ä»ç 11¿ù 15ÀÏ 11:20~12:00 ½Ä»ç ()
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 11:20~11:50 Emerging biomarker strategies for Immuno-Oncology Aurora Seminara(BMS Medical, Immuno-Oncology-Biomarker & Diagnostics)
±³À°½Ã°£ 11¿ù 15ÀÏ Sapphire Room 11:20~12:00 Optimized treatment strategy in mCRC with recent precision medicine À̸í¾Æ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 15ÀÏ Emerald Room 11:20~12:00 Grounreaking efficacy of osimertinib as a new SoC for EGFRm NSCLC management ±èÇý·Ã(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 12:00~12:15 K-MASTER Project ±è¿È«(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 12:15~12:30 Implementation of clinical sequencing in cancer treatment To be announced()
Åä·Ð 11¿ù 15ÀÏ Crystal Ballroom 12:30~13:00 Discussion and Q&A : Regulatory considerations for NGS Oncopanel development Aurora Seminara, ±è¿È« ¿Ü(BMS Medical, Immuno-Oncology-Biomarker & Diagnostics, °í·ÁÀÇ´ë ¿Ü)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 13:00~13:25 Knowledge to practice using cancer genomics À̼¼ÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 13:25~13:50 Genomic and epigenomic profiles of Asian gastrointestinal malignancies Patrick Tan(Duke-NUS Medical School, Singapore)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 13:50~14:15 Title to be announced ±èÁ¾ÀÏ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 14:15~14:40 Implementing cancer genomics into the diagnosis and treatment of pediatric cancer Elaine R. Mardis(Nationwide Children)
ÈÞ½Ä 11¿ù 15ÀÏ 14:40~15:00 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 15:00~15:25 Current status of the Korean Cancer Precision Mecidine Project, K-MASTER ±è¿È«(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 15:25~15:50 Impact of clinical NGS: Lessons lung cancer Jessica Jiyeong Lin(Massachusetts General Hospital Cancer Center, USA)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 15:50~16:15 Updated results and new studies in the nation-wide NGS-based new agent development Atsushi Ohtsu(National Cancer Center Hospital East, Japan)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 16:15~16:40 The future of cancer care through biologic profiling and big data Thomas D. Brown(Swedish Cancer Institute, USA)
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 16:40~17:10 Spotlight on Proferred Papers Session 1 To be announced()